Credo Diagnostics Biomedical Pte Ltd company News and Trends items

1trend

Posted on {{project.publicationDate}}

More information

{{#if project.autoTranslated}} {{{project.nameForDefaultLanguage}}} {{else}} {{{project.name}}} {{/if}}

{{/if}} {{{#if showDetailedInfos}}

(Statut : {{project.starRank}} {{project.publicationDate}})

Posted on 3/25/2024

VitaPCR™ system is capable of detecting the variant EG.5 and its sublineages HV.1, EG.5.1, and HK.3.

Singapore, February 5, 2024 – Update on the Detection of the latest SARS-CoV-2 Variant Credo Diagnostics Biomedical Pte. Ltd. is committed to the post-market monitoring of the reliability of our assays. We have performed nucleotide analysis using the BLASTn method, comparing primers and probes of the assays involving SARS-CoV-2 virus detection to all sequences listed in...

More information

Update On The Detection Of The Latest SARS-CoV-2 Variant

Credo Diagnostics Biomedical Pte Ltd company News and Trends items

Localization Map